MEK1/2
MEK1/2, also known as MAPKK (mitogen-activated protein kinase kinase), is a kinase enzyme which phosphorylates MAPK (mitogen-activated protein kinase).
Products Related to MEK1/2(75)
- GC17030AZD6244(Selumetinib)CAS: 606143-52-6Purity: >99.00%
AZD6244(Selumetinib) is an oral, small molecule, specific ATP non-competitive inhibitor of MEK1/2 proteins, with the IC 50 of 14.1 ± 0.79nM.
- GC30162trans-ZeatinCAS: 1637-39-4Purity: >98.50%
trans-Zeatin is a natural cytokinin, a plant growth regulator that plays a central role in plant cell growth, differentiation, and division.
- GC33305Balamapimod (MKI 833)CAS: 863029-99-6Purity: >98%
Balamapimod (MKI 833) (MKI 833) is a reversible Ras/Raf/MEK inhibitor with potential anti-tumor activity.
- GC33468Rehmannioside ACAS: 81720-05-0Purity: >98.00%
Rehmannioside A is an inhibitor of cytochrome P450 enzymes (CYP3A4, 2C9, and 2D6), with IC 50 values of 10.08, 12.62, and 16.43μM, respectively.
- GC33831Lidocaine hydrochloride (Lignocaine hydrochloride)CAS: 73-78-9Purity: >98.00%
Lidocaine hydrochloride (Lignocaine hydrochloride) is an amino-amide-type local anaesthetic that inhibits voltage-insensitive ‘flicker’ K + channel with an IC 50 value of 220μM.
- GC35684CHMFL-EGFR-202CAS: 2089381-40-6Purity: >98%
CHMFL-EGFR-202 is a potent, irreversible inhibitor of epidermal growth factor receptor (EGFR) mutant kinase, with IC50s of 5.3 nM and 8.3 nM for drug-resistant mutant EGFR T790M and WT EGFR kinases, respectively. CHMFL-EGFR-202 exhibits ?10-fold selectivity for EGFR L858R/T790M against the EGFR wild-type in cells. CHMFL-EGFR-202 adopts a covalent “DFG-in-C-helix-out” inactive binding conformation with EGFR, with strong antiproliferative effects against EGFR mutant-driven nonsmall-cell lung cancer (NSCLC) cell lines.
- GC35719Cobimetinib hemifumarateCAS: 1369665-02-0Purity: >99.00%
Cobimetinib hemifumarate is a novel selective MEK1 inhibitor, and the IC50 value against MEK1 is 4.2 nM.
- GC37516Refametinib R enantiomerCAS: 923032-38-6Purity: >98%
Refametinib R enantiomer is a MEK inhibitor extracted from patent WO2007014011A2, compound 1022, has an EC50 of 2.0-15 nM.
- GC38653Selumetinib sulfateCAS: 943332-08-9Purity: >99.00%
Selumetinib (AZD6244) is selective, non-ATP-competitive oral?MEK1/2?inhibitor, with an IC50 of 14 nM for MEK1. Selumetinib (AZD6244) inhibits ERK1/2 phosphorylation.
- GC41573Theaflavin 3,3'-digallateCAS: 30462-35-2Purity: >98.00%
Theaflavin 3,3'-digallate (TF-3; ZP10) is a potent inhibitor of Zika virus (ZIKV) protease with an IC 50 value of 2.3μM.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC15646 | PD 184161 | 212631-67-9 | >98% | |
MEK1/2 inhibitor | ||||
| GC15693 | BIX 02188 | 334949-59-6 | >99.50% | |
MEK5 inhibitor,potent and selective | ||||
| GC16001 | SCH772984 | 942183-80-4 | >98.50% | |
SCH772984 is a novel, potent, ATP-competitive inhibitor of ERK1 and ERK2 with IC 50 values of 4nM and 1nM, respectively. | ||||
| GC17030 | AZD6244(Selumetinib) | 606143-52-6 | >99.00% | |
AZD6244(Selumetinib) is an oral, small molecule, specific ATP non-competitive inhibitor of MEK1/2 proteins, with the IC 50 of 14.1 ± 0.79nM. | ||||
| GC17426 | Cobimetinib (racemate) | 934662-91-6 | >99.50% | |
| GC17485 | PD 334581 | 548756-68-9 | >98% | |
MEK1 inhibitor | ||||
| GC17608 | Lidocaine | 137-58-6 | >99.50% | |
Anasthetic and class Ib antiarrhythmic agent | ||||
| GC17828 | BI-847325 | 1207293-36-4 | >99.00% | |
dual inhibitor of MEK and Aurora kinases | ||||
| GC17964 | PD 198306 | 212631-61-3 | >98% | |
MEK1/2 inhibitor | ||||
| GC30162 | trans-Zeatin | 1637-39-4 | >98.50% | |
trans-Zeatin is a natural cytokinin, a plant growth regulator that plays a central role in plant cell growth, differentiation, and division. | ||||
| GC33305 | Balamapimod (MKI 833) | 863029-99-6 | >98% | |
Balamapimod (MKI 833) (MKI 833) is a reversible Ras/Raf/MEK inhibitor with potential anti-tumor activity. | ||||
| GC33388 | MEK-IN-1 | 870600-45-6 | >98% | |
MEK-IN-1 is a MEK inhibitor extracted from patent WO2008076415A1. | ||||
| GC33468 | Rehmannioside A | 81720-05-0 | >98.00% | |
Rehmannioside A is an inhibitor of cytochrome P450 enzymes (CYP3A4, 2C9, and 2D6), with IC 50 values of 10.08, 12.62, and 16.43μM, respectively. | ||||
| GC33831 | Lidocaine hydrochloride (Lignocaine hydrochloride) | 73-78-9 | >98.00% | |
Lidocaine hydrochloride (Lignocaine hydrochloride) is an amino-amide-type local anaesthetic that inhibits voltage-insensitive ‘flicker’ K + channel with an IC 50 value of 220μM. | ||||
| GC35684 | CHMFL-EGFR-202 | 2089381-40-6 | >98% | |
CHMFL-EGFR-202 is a potent, irreversible inhibitor of epidermal growth factor receptor (EGFR) mutant kinase, with IC50s of 5.3 nM and 8.3 nM for drug-resistant mutant EGFR T790M and WT EGFR kinases, respectively. CHMFL-EGFR-202 exhibits ?10-fold selectivity for EGFR L858R/T790M against the EGFR wild-type in cells. CHMFL-EGFR-202 adopts a covalent “DFG-in-C-helix-out” inactive binding conformation with EGFR, with strong antiproliferative effects against EGFR mutant-driven nonsmall-cell lung cancer (NSCLC) cell lines. | ||||
| GC35719 | Cobimetinib hemifumarate | 1369665-02-0 | >99.00% | |
Cobimetinib hemifumarate is a novel selective MEK1 inhibitor, and the IC50 value against MEK1 is 4.2 nM. | ||||
| GC36199 | GW284543 | 790186-68-4 | >99.50% | |
GW284543 (UNC10225170) is a selective MEK5 inhibitor. GW284543 reduces pERK5, and decreases endogenous MYC protein. | ||||
| GC37516 | Refametinib R enantiomer | 923032-38-6 | >98% | |
Refametinib R enantiomer is a MEK inhibitor extracted from patent WO2007014011A2, compound 1022, has an EC50 of 2.0-15 nM. | ||||
| GC37522 | RGB-286638 | 784210-87-3 | >99.50% | |
A multi-kinase inhibitor | ||||
| GC37523 | RGB-286638 free base | 784210-88-4 | >98% | |
A multi-kinase inhibitor | ||||
| GC38653 | Selumetinib sulfate | 943332-08-9 | >99.00% | |
Selumetinib (AZD6244) is selective, non-ATP-competitive oral?MEK1/2?inhibitor, with an IC50 of 14 nM for MEK1. Selumetinib (AZD6244) inhibits ERK1/2 phosphorylation. | ||||
| GC41573 | Theaflavin 3,3'-digallate | 30462-35-2 | >98.00% | |
Theaflavin 3,3'-digallate (TF-3; ZP10) is a potent inhibitor of Zika virus (ZIKV) protease with an IC 50 value of 2.3μM. | ||||
| GC43885 | Hypothemycin | 76958-67-3 | >95.00% | |
A resorcylic acid lactone polyketide | ||||
| GC45099 | U-0126 | 109511-58-2 | >98.00% | |
A MEK inhibitor | ||||
